DNAJB1 and cancer: Cancer: Inhibitors can disrupt the Hsp70-Hsp40 complex, impairing cancer cell survivalMalaria: Inhibitors can disrupt the Hsp70-Hsp40 complex, impairing parasite survivalSARS-CoV-2: Inhibitors can disrupt the Hsp70-Hsp40 complex, impairing viral replication